X0508 4 2025-11-04 0001880438 AN2 Therapeutics, Inc. ANTX 0002042268 Prior Stephen David C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025 false true false false Chief Strategy Officer false Common Stock 2025-11-04 4 S false 765 1.14 D 65548 D Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on November 4, 2025. Includes, in accordance with the original terms, (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 and (b) 12,031 RSUs which shall vest on January 1, 2026, in each case, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date. Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on September 30, 2025. /s/ Lucy Day, Attorney-in-Fact for Stephen David Prior 2025-11-06